Sixth Street (TSLX) Q2 2026 earnings review
The Bleeding Stops: NAV Stabilizes, But Growth Remains Frozen
TSLX is out of the ICU. After a brutal Q1 that saw a 4.3% NAV plunge and a dividend cut, Q2 brings desperately needed stability. Net Asset Value (NAV) flatlined exactly at $16.24. More importantly, Net Investment Income (NII) of $0.43 per share fully covered the newly rebased $0.42 base dividend. However, beneath the calm surface, the engine is sputtering: new deal originations collapsed, and leverage crept up to a multi-year high of 1.27x. The company has stopped the downward spiral, but the path back to growth remains heavily obstructed by a frozen M&A market.
🐂 Bull Case
The painful medicine taken in Q1 worked. Re-basing the dividend to $0.42 aligned outflows with the current run-rate of the business. NII of $0.43 proves the new baseline is sustainable even in a low-activity environment.
Credit spread widening continued to be a drag (-$0.04/share), but expanding equity market multiples (+$0.06/share) rode to the rescue, proving the value of TSLX's equity co-investments in defending the balance sheet.
🐻 Bear Case
Q2 new investment commitments fell off a cliff to just $114.6M, a massive deceleration from Q1's $338.1M. The company cannot outrun spread compression without deploying fresh capital.
Debt-to-Equity spiked to 1.27x, up from 1.18x last quarter and 1.10x at the end of 2025. Rising leverage while originations are falling suggests a reliance on the credit facility rather than organic cash flow to manage the balance sheet.
⚖️ Verdict: ⚪
Neutral. Management successfully caught the falling knife. The NAV stability and dividend coverage are exactly what the market demanded. However, the alarming drop in new deal flow and rising leverage prevent a bullish stance until the M&A engine restarts.
Key Themes
The Origination Illusion: Activity Grinds to a Halt
Decelerating. In Q1, management confidently touted a 'better investing environment' with wider spreads and a robust pipeline. The Q2 data directly contradicts this narrative. New investment commitments collapsed to a mere $114.6M across just two portfolio companies. This represents a staggering drop from $338.1M in Q1 and $297.7M a year ago. If TSLX cannot deploy capital, it cannot generate the origination fees necessary to push NII back toward historical levels.
Lower Cost of Debt Cushions the Blow
Accelerating. While top-line Total Investment Income fell 15% YoY (from $115M to $97.8M), the bottom line was shielded by significantly cheaper liabilities. The weighted average interest rate on TSLX's debt outstanding dropped to 5.6%, down notably from 6.3% a year ago. This structural reduction in interest expense is the primary reason NII remained stable despite an anemic top-line.
Leverage Pushes the Envelope
Accelerating. TSLX's Debt-to-Equity ratio climbed to 1.27x at quarter-end, significantly higher than 1.18x in Q1 and 1.09x a year ago. While the company successfully extended its revolving credit facility to 2031, operating this close to the 1.25x historical target ceiling leaves very little dry powder to exploit future market dislocations. The rising leverage profile is particularly concerning given the lack of corresponding portfolio growth.
Structured Credit Partners (SCP) JV Ramping
Stable. The $200M joint venture with Carlyle remains a critical lever for future yield. By investing in newly issued BSL CLO equity in a 'fee-free' format, TSLX expects to generate mid-teens returns. After a $14.7M initial funding in Q1, the company continued calling capital for SCP in Q2. This structural shift toward bespoke, fee-free structured credit acts as a vital counterweight to tight direct lending spreads.
Equity Valuations Save the Quarter
Reversing. In Q1, multiple compression in the equity market drove a painful $0.18/share writedown. In Q2, the macro winds reversed. Expanding market multiples generated $0.06 per share in net unrealized equity gains. This perfectly neutralized the continued macro drag from credit spread widening (which cost $0.04/share), allowing NAV to remain flat.
Software Exposure & Generative AI Risk
Stable. TSLX carries roughly 40% portfolio exposure to enterprise software—the very sector that triggered Q1's brutal markdowns. Management previously argued that AI disruption is an 'equity valuation problem' rather than a credit issue. While the Q2 marks were benign, any resurgence in enterprise tech budget cannibalization by Generative AI tools could rapidly trigger another round of painful multiple compression for these heavily indebted software borrowers.
Other KPIs
Decelerating YoY, but Reversing QoQ. Total revenue fell 15% from $115.0M a year ago due to lower reference rates, but successfully ticked up from $93.4M in Q1. The lack of robust prepayment and origination fees keeps a strict ceiling on top-line growth.
Stable. The portfolio's credit health remains pristine. Non-accruals dropped slightly from 1.4% in Q1. No new portfolio companies were added to non-accrual status this quarter, vindicating management's claim that Q1's NAV drop was driven purely by market spreads, not fundamental credit decay.
Stable. The yield on debt and income-producing securities held exactly flat with Q1 at 11.1%. The freefall in portfolio yield seen throughout 2025 (dropping from 12.3% to 11.3%) appears to have finally found its floor.
Guidance
Stable. Management declared a flat base dividend for Q3, signaling confidence that the $0.42 run-rate established after the Q1 cut is the correct, sustainable floor for the business in the current interest rate environment.
Key Questions
Reconciling the Origination Collapse
Last quarter you highlighted a rapidly improving investment environment and a strong pipeline, yet Q2 commitments plummeted 66% sequentially to $114M. Was this due to deals falling through, heightened competition on terms, or an active decision to pull back?
Leverage Target Re-evaluation
With Debt-to-Equity hitting 1.27x, you are operating slightly above the historical comfort zone. Is this a temporary spike due to timing of repurchases/fundings, or should investors expect TSLX to run at structurally higher leverage going forward?
Software Portfolio Update
Q1 saw significant marks against the software portfolio due to multiple compression. While Q2 equity marks were positive, how is the underlying revenue and EBITDA growth of the ~40% software exposure trending in real-time?